# Of hypertension in pregnancy # :::warning ::: [](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## The decline in cardiovascular diseases ## <div class="alert alert-info" role="alert"> Ektrak mula sa prutas ng cranberry Ektrak mula sa prutas ng appleberry Magnesium L-Arginin Ektrak mula sa dahon at bulaklak ng hawthorn Pulbos ng bulaklak ng hibiscus Ektrak mula sa dahon ng oliba Ektrak mula sa buto ng ubas Ektrak mula sa black currant Coenzyme Q10 Bitamina B6 Folate </div> High blood pressure in pregnancy: causes, risks and Management High blood pressure (arterial hypertension) during pregnancy is a major health Problem that can endanger both the mother and the unborn child. In pregnancy, a distinction between different forms of high blood pressure, including the präexistierende hypertension, pregnancy-associated hypertension and pre-eclampsia. Definition and classification Arterial hypertension in pregnant women is diagnosed if the systolic blood pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg. The classification is done as follows: Präexistierende hypertension: the Presence of a high blood pressure before 20. Week of pregnancy or before the beginning of the pregnancy. Pregnancy-associated hypertension (gestational hypertension): a fall in blood pressure after 20. Week of pregnancy, without proteinuria or other signs of pre-eclampsia. Preeclampsia: high blood pressure after 20. Week of pregnancy in combination with proteinuria (≥300 mg of Protein per 24 hours), or other organ investments (e.g., liver function tests, platelet count, renal function, cerebral or visual symptoms). Eclampsia: seizures Occur in a woman with pre-eclampsia, which cannot be attributed to other causes. Causes and risk factors The present state of knowledge, the emergence of hypertension is based in pregnancy to impaired placentation development. In the case of pre-eclampsia it comes to inadequate remodeling of the uterine arteries, which leads to decreased Placental blood flow, and thus to hypoxia. This in turn triggers a series of endothelial and immunological reactions. Among the most important risk factors: First Pregnancy (Primigravidität) Pre-existing hypertension or Diabetes mellitus Family history of pre-eclampsia Multiple pregnancy Age above 35 years Overweight or obesity (BMI &gt;30 kg/m 2 ) Clinical symptoms and complications In addition to the increased blood pressure, the following symptoms may occur: Edema, especially of the hands and face Protein in the urine (proteinuria) Headache, Blurred Vision Upper abdominal pain (due to liver involvement) Thrombocytopenia (low platelet count) Maternal complications include: Stroke Renal failure HELLP syndrome (hemolysis, elevated liver enzymes, low platelets) Eclampsia For the child risks are: Growth retardation Premature birth Plazental insufficiency Perinatal Mortality Diagnostics and Monitoring The diagnostics includes: Regular Blood Pressure Measurement Urine analysis for the determination of proteinuria Laboratory Tests (Kidney Values, Liver Enzymes, Platelets, Haemoglobin) Ultrasound examination for the evaluation of the Fetalwachstums and the placenta due to bleeding Doppler sonography of the A. umbilicalis Therapeutic Management The Management depends on the Severity of the high blood pressure and gestational age: In the case of pregnancy-associated hypertension without severe symptoms: closer Monitoring, may antihypertensives (such as Methyldopa, nifedipine). In pre-eclampsia with severe symptoms: stationary Monitoring, antihypertensive agents to lower blood pressure, magnesium sulfate to spasm prevention, consideration of a premature birth. In the case of eclampsia: immediate treatment with magnesium sulfate and blood pressure control, rapid delivery. Prevention Women with high-risk (e.g., pre-Diabetes) can of prophylactic administration of acetylsalicylic acid (Aspirin) from the 12. Pregnancy week benefit. In addition, healthy lifestyle habits (for balanced diet, regular physical activity, weight control) are of great importance. Conclusion Hypertension in pregnancy is a multifactorial and potentially life-threatening syndrome. Early diagnosis, a structured Monitoring and a differentiated therapeutic approach are essential in order to minimize maternal and fetal complications, and to ensure a favorable prognosis for both mother and child. If you want, I can make certain sections in more detail or additional information to add! > Ang arteryal na hypertension o hypertension ay isang kondisyon ng patuloy na systolic at diastolic na presyon ng dugo, kung saan ang mga sukatan ay lumalagpas sa 140/90 mmHg. Ang mataas na presyon ay nagpapakita ng mga hindi komportableng sintomas.  <a href="http://infotechsystemsonline.com/ital/www/img/tablets-of-hypertension-ambulance-7848.xml">Of hypertension in pregnancy</a> Ang presyon ng dugo ay isa sa mga pangunahing indikasyon ng kalusugan, na hindi lamang sumasalamin sa puso at sistema ng sirkulasyon, kundi pati na rin sa aktibidad ng mga bato, mga organo ng endokrin, paggawa ng dugo, at ng sistema ng nerbiyos. Kaya naman, walang isang unibersal na gamot laban sa mataas na presyon ng dugo. Hindi ka basta basta puwedeng pumunta sa botika at magtanong ng 'tableta para sa presyon,' kasi agad na tatanungin ng parmasyutiko – anong gamot ang nireseta sa iyo ng doktor? <a href="http://www.dambi.pl/userfiles/the-installed-disease-of-the-cardiovascular-disease-6853.xml">PUMUNTA SA WEBSITE>>> </a> ## Calculator Cardiovascular Diseases ## Calculator in the prediction and evaluation of cardiovascular diseases In modern cardiological practice, mathematical models and risk calculations play a Central role in the early detection and prevention of cardiovascular disease (CVD). Simple calculator, as well as specialized digital Tools that allow Doctors and patients to calculate important parameters quickly and conveniently — without the need for complex Software. Important indicators for the assessment of cardiovascular risk Among the basic indicators, which are often determined by using a pocket calculator: Body Mass Index (BMI): The BMI is calculated according to the formula: BMI= (Gr o ße in m) 2 K o body weight in kg A BMI over 30 kg/m 2 apply as obesity, a known risk factor for CVD. Blood pressure and mean arterial pressure (MAP): The MAP can be approximated with the following formula:a MAP=DBP+ 3 1 ⋅(SBP−DBP) where SBP is the systolic and DBP is the diastolic blood pressure. Increased MAP indicates an increased load on the cardiovascular system. Cholesterol Ratios: The ratio of total Cholesterol to HDL‑Cholesterol (good Cholesterol) is an important predictor: Cholesterol Ratio a ratio= HDL‑Cholesterol Total Cholesterol Values above 5 are considered to be unfavorable. Risk scale Framingham: Although complex, can be applied to a simplified Version of this scale with a calculator, the 10‑year estimate of risk for coronary heart disease. Factors such as age, gender, blood pressure, cholesterol values, and Smoking behavior. Practical application in daily clinical practice A simple calculator allows you to: fast calculation of BMI at each physical examination; Review of dose recommendations (e.g. mg/kg body weight); Calculation of infusion rates or drug concentrations; Determination of renal filtration rates (e.g., according to the MDRD formula or the Cockcroft‑Gault formula); Assessment of the cardiovascular overall scale risk according to the Standard. Limitations of the simple calculation Although calculators are useful to interpret the results in a clinical context. So a normal BMI may be associated with increased visceral fat. Simple formulas do not take into account all individual risk factors (e.g. family history, chronic inflammation). Conclusion The use of calculators for calculating cardiovascular parameters diseases is an essential tool in the prevention and diagnosis of cardiovascular disease. You can support the decision-making, require a critical medical Interpretation. In the future, digital computers, and mobile Apps will Refine these features and integrate without having to replace the basis of the mathematical analysis. <a href="https://hedgedoc.private.coffee/s/Orm4jm_Xf">Calculator Cardiovascular Diseases</a> ** Of hypertension in pregnancy **. The decline in cardiovascular diseases: causes and prospects In the last few decades, there has been in many developed countries, a significant decline in mortality due to cardiovascular disease (CVD). This Trend is the result of a combination of medical advances, preventative measures, and social changes. One of the most important factors for the reduction of CVD mortality, the improvement of diagnostic and therapeutic methods. The development of effective drugs — such as statins to lower cholesterol, antihypertensive drugs to control blood pressure, as well as anticoagulants for the prevention of thrombosis has improved the prognosis for patients with cardiovascular risk factors. In addition, invasive procedures such as coronary angiography, Percutaneous Coronary Intervention (PCI) and coronary Bypass surgery have revolutionized the treatment of acute heart attacks and coronary heart disease. Another important aspect is the prevention. Health campaigns aimed at the reduction of risk factors, play a Central role. These risk factors include: Smoking unhealthy diet, lack of physical activity, Overweight and obesity, chronically elevated blood pressure (hypertension), Diabetes mellitus. Through public awareness and political measures (such as tobacco tax increases, Werarkungsstandards and promotion of sports offered) could be reduced in many regions, the prevalence of these risk factors. For example, studies show that the number of smokers in Europe has decreased in the last 30 years, significant, which has directly contributed to the reduction of heart attacks and strokes. In addition, it has spread the awareness for a healthy way of life. The introduction of Screening programmes for the early detection of hypertension, hypercholesterolemia and Diabetes, and allows for early Intervention and thus prevention of serious consequences. Despite these positive developments, challenges remain, however. In some population groups, particularly in socially disadvantaged strata of society, the incidence of CVD remains high. In addition, the prevalence of obesity and Diabetes in some regions, continue to rise, which could threaten the long-term progress in the reduction of CVD. In summary, one can say that the decline in cardiovascular disease is due to a combination of medical advances, more effective prevention and social awareness. In order to secure this positive development in the long term, however, continuous investments in research, health promotion and social equality is required. Would you like me to make a certain section in more detail or additional aspects into account? - [x] <a href="https://md.interhacker.space/s/Vh-s4HMrb">The decline in cardiovascular diseases</a> - [x] <a href="https://www.multicarehomeopathy.com/userfiles/the-heart-to-heart-a-rest-vascular-diseases-8321.xml">Calculator Cardiovascular Diseases</a> - [x] <a href="https://www.michaelkenna.net/user_images/heart-health-cardiovascular-disease-4707.xml">Violation of cardiovascular diseases</a> - [x] <a href="https://md.mandragot.org/s/N2g3xsI5Vo">https://md.mandragot.org/s/N2g3xsI5Vo</a> <a href="https://pad.stuve.de/s/aF7kZcUjC">https://pad.stuve.de/s/aF7kZcUjC</a> <a href="https://hedgedoc.stusta.de/s/PIyyjfue2">https://hedgedoc.stusta.de/s/PIyyjfue2</a> <a href="https://pad.geolab.space/s/J9jAavfn0">https://pad.geolab.space/s/J9jAavfn0</a> <a href="https://md.coredump.ch/s/XseHHrOCY">https://md.coredump.ch/s/XseHHrOCY</a> <a href="https://hedgedoc.faimaison.net/s/rMkuP1csAx">https://hedgedoc.faimaison.net/s/rMkuP1csAx</a> <a href="https://md.nolog.cz/s/aj2uuAMup">https://md.nolog.cz/s/aj2uuAMup</a> <a href="https://pad.c3voc.de/s/j7Tt88T2Z">https://pad.c3voc.de/s/j7Tt88T2Z</a> <a href="https://doc.fung.uy/s/jtLM8HHLZ3">https://doc.fung.uy/s/jtLM8HHLZ3</a> <a href="https://pad.nantes.cloud/s/K12zIZFOMr">https://pad.nantes.cloud/s/K12zIZFOMr</a> <a href="https://pad.cttue.de/s/sLw2bv0nR">https://pad.cttue.de/s/sLw2bv0nR</a> <a href="https://notes.llgoewer.de/s/x6TU2Xmr9">https://notes.llgoewer.de/s/x6TU2Xmr9</a> <a href="https://text.fraction.jp/s/3gOVpbS-W">https://text.fraction.jp/s/3gOVpbS-W</a> <a href="https://pad.flipdot.org/s/Q9GVNkHZ0t">https://pad.flipdot.org/s/Q9GVNkHZ0t</a> <a href="https://pad.stuve.de/s/Eo1N6mI_l">https://pad.stuve.de/s/Eo1N6mI_l</a> <a href="https://md.chaosdorf.de/s/qJhUYyVfz_">https://md.chaosdorf.de/s/qJhUYyVfz_</a> <a href="https://pad.eisfunke.com/s/lrP4ybK7vg">https://pad.eisfunke.com/s/lrP4ybK7vg</a> <a href="https://md.studibla.ch/s/SEjg9n8sqM">https://md.studibla.ch/s/SEjg9n8sqM</a> <a href="https://pad.multiplace.org/s/SkyILv9Mze">https://pad.multiplace.org/s/SkyILv9Mze</a> <a href="https://pad.wolkenbar.de/s/ukT_zl-Rdx">https://pad.wolkenbar.de/s/ukT_zl-Rdx</a> <a href="https://hedgedoc.timon.ch/s/4GvZCavC2">https://hedgedoc.timon.ch/s/4GvZCavC2</a> <a href="https://editor.celtoi.org/s/d-eWhuNAh">https://editor.celtoi.org/s/d-eWhuNAh</a> <a href="https://hedgedoc.nrp-nautilus.io/s/iHtzoPvkP8">https://hedgedoc.nrp-nautilus.io/s/iHtzoPvkP8</a> <a href="https://hedgedoc.c3d2.de/s/liNs0JLAgI">https://hedgedoc.c3d2.de/s/liNs0JLAgI</a> <a href="https://markdown.iv.cs.uni-bonn.de/s/QsWnxpEAW">https://markdown.iv.cs.uni-bonn.de/s/QsWnxpEAW</a> <a href="https://md.sigma2.no/s/HQ-X1FKAf">https://md.sigma2.no/s/HQ-X1FKAf</a> <a href="https://pad.deckenpfronn.info/s/NYLd-Tsic">https://pad.deckenpfronn.info/s/NYLd-Tsic</a> <a href="https://hack.utopia-lab.org/s/cMmqaUWC2">https://hack.utopia-lab.org/s/cMmqaUWC2</a> <a href="https://md.gafert.org/s/SrXXdjLW2">https://md.gafert.org/s/SrXXdjLW2</a> <a href="https://pad.ccc-p.org/s/kCKXMALUiA">https://pad.ccc-p.org/s/kCKXMALUiA</a> <a href="https://notes.ip2i.in2p3.fr/s/cRzCKUYzM">https://notes.ip2i.in2p3.fr/s/cRzCKUYzM</a> <a href="https://hedge.grin.hu/s/TtTutCqiki">https://hedge.grin.hu/s/TtTutCqiki</a> <a href="https://doc.interscalar.eu/s/x9R4ExR4B">https://doc.interscalar.eu/s/x9R4ExR4B</a> <a href="https://md.infs.ch/s/Tch0UiiRhu">https://md.infs.ch/s/Tch0UiiRhu</a> <a href="https://md.interhacker.space/s/wZIc-Szma">https://md.interhacker.space/s/wZIc-Szma</a> <a href="https://notas.laotra.red/s/fedh9ByQQ3">https://notas.laotra.red/s/fedh9ByQQ3</a> <a href="https://hedgedoc.stura-ilmenau.de/s/kPQwlVn7Tx">https://hedgedoc.stura-ilmenau.de/s/kPQwlVn7Tx</a> <a href="https://pad.koeln.ccc.de/s/GsZKUZBTL">https://pad.koeln.ccc.de/s/GsZKUZBTL</a> <a href="https://notes.medien.rwth-aachen.de/s/qa5U7-Uc47">https://notes.medien.rwth-aachen.de/s/qa5U7-Uc47</a> <a href="https://omoffice.de/s/ryB_IwqfMe">https://omoffice.de/s/ryB_IwqfMe</a> <a href="https://codimd.pirati.cz/s/80cVUVTEz">https://codimd.pirati.cz/s/80cVUVTEz</a> <a href="https://md.globenet.org/s/JaTN0z8HP">https://md.globenet.org/s/JaTN0z8HP</a> <a href="https://notes.phys-el.ru/s/wRRODVlJOb">https://notes.phys-el.ru/s/wRRODVlJOb</a> <a href="https://hedgedoc.inqbus.de/s/TVXVhk1P5">https://hedgedoc.inqbus.de/s/TVXVhk1P5</a> <a href="https://hedgedoc.eclair.ec-lyon.fr/s/zordxMvne">https://hedgedoc.eclair.ec-lyon.fr/s/zordxMvne</a> <a href="https://hackmd.hub.yt/s/XktMrqI8z">https://hackmd.hub.yt/s/XktMrqI8z</a> <a href="https://pad.demokratie-dialog.de/s/qwLTCoI8zO">https://pad.demokratie-dialog.de/s/qwLTCoI8zO</a> <a href="https://doc.neutrinet.be/s/YJk4S5pRyp">https://doc.neutrinet.be/s/YJk4S5pRyp</a> <a href="https://hedgedoc.ichmann.de/s/2O8fJjIsCc">https://hedgedoc.ichmann.de/s/2O8fJjIsCc</a> <a href="https://hedgedoc.obermui.de/s/HbdqQdcNTz">https://hedgedoc.obermui.de/s/HbdqQdcNTz</a> <a href="https://codi.sevenvm.de/s/qbkr0j-L5">https://codi.sevenvm.de/s/qbkr0j-L5</a> <a href="https://md.bytewerk.org/s/dRUuTTAp55">https://md.bytewerk.org/s/dRUuTTAp55</a> <a href="https://doc.spiegie.de/s/Mc0raG3-v">https://doc.spiegie.de/s/Mc0raG3-v</a> <a href="https://www.notizen.kita.bayern/s/6Z3up1msh6">https://www.notizen.kita.bayern/s/6Z3up1msh6</a> <a href="https://hedgedoc.ctf.mcgill.ca/s/YQqfp_Gw0">https://hedgedoc.ctf.mcgill.ca/s/YQqfp_Gw0</a> <a href="https://hedgedoc.team23.org/s/iFvysm8-ws">https://hedgedoc.team23.org/s/iFvysm8-ws</a> <a href="https://doc.hkispace.com/s/680Cz7_BW">https://doc.hkispace.com/s/680Cz7_BW</a> <a href="https://pad.dominick-leppich.de/s/NxWmMMP9S">https://pad.dominick-leppich.de/s/NxWmMMP9S</a> <a href="https://pads.dgnum.eu/s/vttFzyiLde">https://pads.dgnum.eu/s/vttFzyiLde</a> <a href="https://doc.cisti.org/s/UIhdGPJEV6">https://doc.cisti.org/s/UIhdGPJEV6</a> ## Violation of cardiovascular diseases ## Injuries associated with cardiovascular disease: pathophysiology and clinical relevance Cardiovascular diseases (CVD) are one of the leading causes of death worldwide and represent a significant Problem for the health system. In the context of these diseases, various injuries can occur, which may be direct consequences of the disease development, as well as complications of treatment. Definition and classification Under an injury in the context of CVD refers to a structural or functional damage to the organs or tissues of the cardiovascular system. Such injuries can be broadly classified into the following categories: Myocardial injury, including myocardial infarction and ischemic damage. Vascular lesions, such as aneurysms, dissections, or vascular Rupture. Valve damage caused by endocarditis, degenerative changes or Trauma. Arrhythmogenic damage, which can lead to a disturbed electrical activity of the heart. Pathophysiological Mechanisms Dieusschlaggebenden pathophysiological processes in CVD-associated injuries are many and varied: Atherosclerosis: deposition of lipids in the vascular wall leads to plaque formation that restricts the blood flow to and in the progression can lead to thrombi and emboli. Ischemia and Reperfusion: A reduced supply of oxygen to the myocardium (ischemia) leads to cell damage. In the case of restoration of blood flow (Reperfusion), it can, however, lead to oxidative damage. Inflammation: Chronic inflammation play a Central role in the Progression of atherosclerosis and in the pathogenesis of myocarditis. Mechanical stress: Increased blood pressure (hypertension) and structural changes of the heart (e.g., dilation) lead to increased wall tension and thus to further damage. Clinical Manifestations The clinical symptoms depend on the type and localization of the injury: In the case of a myocardial infarction retro occur typically sternal pain, shortness of breath, and Nausea. An aortic dissection often manifests as sudden, spasmodic pain in the chest or back. Heart valve defects can lead to Fatigue, Edema, and heart sounds. Arrhythmias can range from palpitations to cardiac arrest. Diagnostics For the diagnosis of injuries in the case of CVD, various methods are used: Electrocardiogram (ECG) Echocardiography (ultrasound of the heart) Laboratory parameters (e.g., Troponin, NT‑proBNP) Coronary angiography Computed tomography (CT) and magnetic resonance imaging (MRI) Therapeutic Approaches The therapy depends on the type of injury, and includes: Drug treatment (anticoagulants, beta-blockers, ACE‑inhibitors) Interventional procedures (PTCA, stent implantation) Surgical Procedures (Coronary Bypass, Valve Replacement) Implantable Devices (Defibrillators, Pacemakers) Conclusion Violations in the context of cardiovascular disease are multifactorial and require a differentiated diagnosis and therapy. The early detection and adequate treatment can improve the prognosis of the patient significantly and the quality of life. Further research is necessary to develop new preventive and therapeutic approaches.